{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:16:29Z","timestamp":1788365789897,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J3829"],"award-info":[{"award-number":["2025A03J3829"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010256","name":"Guangzhou Municipal Science and Technology Project","doi-asserted-by":"publisher","award":["2025A03J3928"],"award-info":[{"award-number":["2025A03J3928"]}],"id":[{"id":"10.13039\/501100010256","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202273"],"award-info":[{"award-number":["82202273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572343"],"award-info":[{"award-number":["82572343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ymthe.2026.06.035","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T06:55:34Z","timestamp":1782543334000},"page":"5399-5425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["HSP90\u03b1-USP7-DNMT1 axis drives HCC recurrence after microwave ablation by disrupting ACSS3-mediated propionate metabolism"],"prefix":"10.1016","volume":"34","author":[{"given":"Ye","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinkun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kangshun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyu","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zebing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bixiang","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyue","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9581","authenticated-orcid":false,"given":"Yin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2026.06.035_bib1","first-page":"498","article-title":"Advances in the treatment of hepatocellular carcinoma: an overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Moris","year":"2025","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.06.035_bib2","first-page":"10","article-title":"Improving surgical treatments for hepatocellular carcinoma","volume":"23","author":"Malik","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib3","first-page":"S168","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000522134","article-title":"Period-dependent survival benefit of percutaneous microwave ablation for hepatocellular carcinoma: a 12-year real-world, multicentric experience","volume":"11","author":"Yu","year":"2022","journal-title":"Liver Cancer"},{"key":"10.1016\/j.ymthe.2026.06.035_bib5","doi-asserted-by":"crossref","DOI":"10.1080\/02656736.2025.2524389","article-title":"Microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score matching and inverse probability weighting analysis","volume":"42","author":"Yang","year":"2025","journal-title":"Int. J. Hyperthermia"},{"key":"10.1016\/j.ymthe.2026.06.035_bib6","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/cncr.24196","article-title":"Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors","volume":"115","author":"Yin","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ymthe.2026.06.035_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/RLI.0000000000001100","article-title":"Local ablation therapy for hepatocellular carcinoma: clinical significance of tumor size, location, and biology","volume":"60","author":"Lee","year":"2025","journal-title":"Invest. Radiol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib8","article-title":"Optimal treatment for small HCC (< 3 cm): resection, liver transplantation, or locoregional therapy?","volume":"5","author":"Wu","year":"2023","journal-title":"JHEP Rep."},{"key":"10.1016\/j.ymthe.2026.06.035_bib9","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.3390\/cancers17162656","article-title":"Clinical and imaging-based prognostic models for recurrence and local tumor progression following thermal ablation of hepatocellular carcinoma: a systematic review","volume":"17","author":"Verhagen","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ymthe.2026.06.035_bib10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2147\/JHC.S409011","article-title":"Clinical results, risk factors, and future directions of ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma","volume":"10","author":"Dong","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.ymthe.2026.06.035_bib11","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1007\/s00330-012-2438-x","article-title":"MR-guided radiofrequency ablation using a wide-bore 1.5-T MR system: clinical results of 213 treated liver lesions","volume":"22","author":"Rempp","year":"2012","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2021.06.001","article-title":"Sublethal heat stress-induced O-GlcNAcylation coordinates the Warburg effect to promote hepatocellular carcinoma recurrence and metastasis after thermal ablation","volume":"518","author":"Chen","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ymthe.2026.06.035_bib13","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1002\/hep.26526","article-title":"Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma","volume":"58","author":"Yoshida","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2026.06.035_bib14","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1038\/s41388-018-0169-4","article-title":"Stress-induced phosphoprotein 1 mediates hepatocellular carcinoma metastasis after insufficient radiofrequency ablation","volume":"37","author":"Su","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ymthe.2026.06.035_bib15","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.ymthe.2022.08.004","article-title":"Targeting N(7)-methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation","volume":"31","author":"Zhu","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2026.06.035_bib16","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1158\/2159-8290.CD-24-0296","article-title":"The epigenetic hallmarks of cancer","volume":"14","author":"Esteller","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ymthe.2026.06.035_bib17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1038\/s41588-021-00926-8","article-title":"Single-cell multimodal glioma analyses identify epigenetic regulators of cellular plasticity and environmental stress response","volume":"53","author":"Johnson","year":"2021","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2026.06.035_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.semcancer.2020.12.022","article-title":"Targeting epigenetic regulatory machinery to overcome cancer therapy resistance","volume":"83","author":"Guo","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib19","first-page":"376","article-title":"Cancer epigenetics in clinical practice","volume":"73","author":"Davalos","year":"2023","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.ymthe.2026.06.035_bib20","first-page":"10","article-title":"Epigenetic editing: from concept to clinic","volume":"25","author":"Heller","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ymthe.2026.06.035_bib21","doi-asserted-by":"crossref","first-page":"7875","DOI":"10.1038\/s41467-024-52202-y","article-title":"Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models","volume":"15","author":"Senapedis","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib22","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/j.cmet.2024.07.014","article-title":"Amelioration of nonalcoholic fatty liver disease by inhibiting the deubiquitylating enzyme RPN11","volume":"36","author":"Zhou","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2026.06.035_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13045-024-01601-1","article-title":"Heat shock proteins as hallmarks of cancer: insights from molecular mechanisms to therapeutic strategies","volume":"17","author":"Zuo","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib24","doi-asserted-by":"crossref","first-page":"7310","DOI":"10.1038\/s41467-024-51614-0","article-title":"Pramel15 facilitates zygotic nuclear DNMT1 degradation and DNA demethylation","volume":"15","author":"Tan","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ymthe.2026.06.035_bib26","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1038\/s41467-023-37659-7","article-title":"HSP90 provides a platform for kinase dephosphorylation by PP5","volume":"14","author":"Jaime-Garza","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib27","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41467-018-03024-2","article-title":"Dynamic network biomarker indicates pulmonary metastasis at the tipping point of hepatocellular carcinoma","volume":"9","author":"Yang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib28","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tig.2021.05.002","article-title":"Navigating the DNA methylation landscape of cancer","volume":"37","author":"Nishiyama","year":"2021","journal-title":"Trends Genet."},{"key":"10.1016\/j.ymthe.2026.06.035_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.trecan.2024.11.003","article-title":"Short-chain fatty acids and cancer","volume":"11","author":"Li","year":"2025","journal-title":"Trends Cancer"},{"key":"10.1016\/j.ymthe.2026.06.035_bib30","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jhep.2022.11.017","article-title":"Decreased propionyl-CoA metabolism facilitates metabolic reprogramming and promotes hepatocellular carcinoma","volume":"78","author":"Sun","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41420-025-02554-1","article-title":"The role and mechanism of fatty acid oxidation in cancer drug resistance","volume":"11","author":"Lei","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ymthe.2026.06.035_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0005-2760(94)90259-3","article-title":"Hepatic carnitine palmitoyltransferase-I has two independent inhibitory binding sites for regulation of fatty acid oxidation","volume":"1212","author":"Kashfi","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ymthe.2026.06.035_bib33","doi-asserted-by":"crossref","first-page":"H1215","DOI":"10.1152\/ajpheart.00016.2017","article-title":"A comprehensive analysis of myocardial substrate preference emphasizes the need for a synchronized fluxomic\/metabolomic research design","volume":"312","author":"Ragavan","year":"2017","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib34","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.3390\/biomedicines11051334","article-title":"Targeted DNA demethylation: vectors, effectors and perspectives","volume":"11","author":"Yano","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ymthe.2026.06.035_bib35","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.7150\/thno.30867","article-title":"GRP78-targeted ferritin nanocaged ultra-high dose of doxorubicin for hepatocellular carcinoma therapy","volume":"9","author":"Jiang","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.ymthe.2026.06.035_bib36","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12951-022-01554-y","article-title":"Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma","volume":"20","author":"Zheng","year":"2022","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.ymthe.2026.06.035_bib37","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1039\/D3TB02560H","article-title":"Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cells","volume":"12","author":"Jiao","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ymthe.2026.06.035_bib38","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.14309\/ajg.0000000000000931","article-title":"Hepatocellular carcinoma: a contemporary approach to locoregional therapy","volume":"115","author":"Ahmed","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib39","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","article-title":"Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"16","author":"Bruix","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib40","doi-asserted-by":"crossref","first-page":"S168","DOI":"10.1016\/j.jhep.2026.01.006","article-title":"Updated data from IMBRAVE050: adjuvant atezolizumab plus bevacizumab for high-risk hepatocellular carcinoma","volume":"84","author":"Yopp","year":"2026","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib41","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41576-024-00760-8","article-title":"DNA methylation in mammalian development and disease","volume":"26","author":"Smith","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ymthe.2026.06.035_bib42","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/hep.31659","article-title":"DNA methylation profiling of human hepatocarcinogenesis","volume":"74","author":"Hernandez-Meza","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.ymthe.2026.06.035_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41392-025-02266-z","article-title":"Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance","volume":"10","author":"Song","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.06.035_bib44","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1046\/j.1432-1033.2002.03198.x","article-title":"DNMT3A and DNMT1 functionally cooperate during de novo methylation of DNA","volume":"269","author":"Fatemi","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ymthe.2026.06.035_bib45","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41594-021-00603-8","article-title":"DNMT1 has de novo activity targeted to transposable elements","volume":"28","author":"Haggerty","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib46","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nn.2514","article-title":"DNMT1 and DNMT3A maintain DNA methylation and regulate synaptic function in adult forebrain neurons","volume":"13","author":"Feng","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ymthe.2026.06.035_bib47","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41580-023-00640-9","article-title":"Structural and functional complexity of HSP90 in cellular homeostasis and disease","volume":"24","author":"Chiosis","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.01.005","article-title":"Compartmentalised acyl-CoA metabolism and roles in chromatin regulation","volume":"38","author":"Trefely","year":"2020","journal-title":"Mol. Metab."},{"key":"10.1016\/j.ymthe.2026.06.035_bib49","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.cmet.2025.01.005","article-title":"The emerging role of dysregulated propionate metabolism and methylmalonic acid in metabolic disease, aging, and cancer","volume":"37","author":"Shafer","year":"2025","journal-title":"Cell Metab."},{"key":"10.1016\/j.ymthe.2026.06.035_bib50","doi-asserted-by":"crossref","DOI":"10.4028\/b-XDTcg5","article-title":"Methionine metabolism dictates PCSK9 expression and antitumor potency of PD-1 blockade in MSS colorectal cancer","volume":"12","author":"Wang","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.06.035_bib51","doi-asserted-by":"crossref","first-page":"28480","DOI":"10.1021\/acsnano.4c06369","article-title":"Immune implications of cholesterol-containing lipid nanoparticles","volume":"18","author":"Back","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.ymthe.2026.06.035_bib52","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.ymthe.2026.06.035_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202206150","article-title":"Erythrocyte-inspired functional materials for biomedical applications","volume":"10","author":"Luo","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ymthe.2026.06.035_bib54","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000294","article-title":"HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS\/PDHC hyperacetylation","volume":"7","author":"Bei","year":"2023","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib55","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/nature10008","article-title":"Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation","volume":"473","author":"Ficz","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ymthe.2026.06.035_bib56","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/978-1-0716-1593-5_12","article-title":"Bimolecular fluorescence complementation (BiFC) and multiplexed imaging of protein-protein interactions in human living cells","volume":"2350","author":"Jia","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ymthe.2026.06.035_bib57","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/s41392-020-00453-8","article-title":"HIF-1\u03b1-induced expression of m6A reader YTHDF1 drives hypoxia-induced autophagy and malignancy of hepatocellular carcinoma by promoting ATG2A and ATG14 translation","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ymthe.2026.06.035_bib58","article-title":"Intratumoral lactate depletion based on injectable nanoparticles-hydrogel composite system synergizes with immunotherapy against postablative hepatocellular carcinoma recurrence","volume":"13","author":"Chen","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ymthe.2026.06.035_bib59","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1038\/s41467-023-36881-7","article-title":"MTORC1 upregulates B7-H3\/CD276 to inhibit antitumor t cells and drive tumor immune evasion","volume":"14","author":"Liu","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymthe.2026.06.035_bib60","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1073\/pnas.0810932106","article-title":"Demonstration of the ethylmalonyl-CoA pathway by using 13C metabolomics","volume":"106","author":"Peyraud","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001626005137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:22:12Z","timestamp":1788362532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001626005137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":60,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1525001626005137"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.035","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HSP90\u03b1-USP7-DNMT1 axis drives HCC recurrence after microwave ablation by disrupting ACSS3-mediated propionate metabolism","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2026.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}